Indian drug regulator backs off over use of Roche’s Avastin
The Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to treat age-related degeneration.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news